Brought to you by 
Adimab, Innovent partner on antibody development
03 Feb 2023
Executive Summary
Fellow antibody companies Adimab LLC (mAb and biospecific antibody discovery) and Innovent Biologics Inc. (antibody therapeutics development and manufacturing) teamed up to discover, develop, and commercialize a therapeutic antibody program.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Technologies
- Synthesis Technologies, Production Processes
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Adimab, Innovent partner on antibody development
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice